Feb 27, 2018
Prime Therapeutics Surpasses 1 Million Medicaid Members
Feb 20, 2018
Prime Therapeutics Proves PBMs' Value: Delivers Negative Drug Trend in 2017
Jan 29, 2018
Prime Therapeutics and Boehringer Ingelheim Enter Into Outcomes-Based Contract for Jardiance®
Jan 08, 2018
Prime Therapeutics Pharmacist Elected to Academy of Managed Care Pharmacy Board of Directors
Dec 08, 2017
Prime Therapeutics Signs Outcomes-Based Contract with Novo Nordisk for Type 2 Diabetes Drug Victoza® (liraglutide)
Dec 01, 2017
Prime Therapeutics Signs CareCentered Contract(TM) with leading manufacturer of Multiple Sclerosis drugs
Oct 30, 2017
Prime Therapeutics Applauds Cross-Functional Opioid Epidemic Report from Clinton Foundation and Johns Hopkins Bloomberg School of Public Health
Oct 23, 2017
New Public Opinion Survey Finds Few Safely Dispose of Unused Medicine, Most Opioid Users Weren't Told About the Potential for Opioid Addiction
Oct 17, 2017
Prime Therapeutics' Studies Examine Rheumatoid Arthritis Therapies and Total Cost
Oct 16, 2017
Prime Therapeutics Controlled Substance Management Program Helped Decrease Opioid Use Among Those at Highest Risk
Oct 13, 2017
Prime Therapeutics Study Finds a Diabetes Drugs Value Based Insurance Design Improves Adherence, Doesn't Lower Total Cost of Care
Oct 12, 2017
Mid-Year Drug Trend: Prime held spending increases to 0.8% for commercial clients, generated negative trend for government program clients
Oct 02, 2017
AllianceRx Walgreens Prime Begins Launch of its New Brand
Jul 20, 2017
Prime Therapeutics Urges Caution on Mandates of Abuse-Deterrent Formulations of Opioids Citing Value Concerns